29 articles in this topic
New trial data reveals AstraZeneca's experimental in vivo CAR-T therapy showed early responses in multiple myeloma patients but resulted in one death.
New biotech innovations are advancing prostate cancer therapy with promising approaches for better patient outcomes.
Key biotech companies developing T cell engager therapies that redirect immune cells to fight cancer more effectively.
Australian biotech company creates targeted treatment that attacks malignant plasma cells while sparing healthy ones in multiple myeloma patients.
Revolutionary CRISPR technique bypasses lab manufacturing by programming immune cells to fight cancer directly in the body.
